Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief: that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development. Data-driven decision-making in turn will lead to cures for patients around the world becoming available faster.
The Relay Innovation Engine software platform powers the Business Development Live! (BD Live!) software-as-a-service and our strategy consulting practice, which supports business development and corporate strategy professionals by aggregating scientific, business and medical data in an actionable context. Relay works with life science companies to increase the efficiency of drug development by offering a transparent, objective and scalable approach to business intelligence and analytics.
Relay was founded by David Greenwald, Ph.D. and Brigham Hyde, Ph.D.
